Author:
Oreja-Guevara Celia,Brownlee Wallace,Celius Elisabeth G.,Centonze Diego,Giovannoni Gavin,Hodgkinson Suzanne,Kleinschnitz Christoph,Havrdova Eva Kubala,Magyari Melinda,Selchen Daniel,Vermersch Patrick,Wiendl Heinz,Van Wijmeersch Bart,Salloukh Hashem,Yamout Bassem
Subject
Neurology (clinical),Neurology,General Medicine
Reference69 articles.
1. Disease activity after cladribine immune reconstitution therapy: to repeat or to retreat?;Allen-Philbey;Neurology,2022
2. Relapse-free and neda status with cladribine in a real life population: a multicentre study;Annovazzi;Mult. Scler.,2020
3. Two year relapse-free and NEDA status with Cladribine in a real-life population: a multicentre study;Annovazzi;Mult. Scler.,2021
4. Early real-world safety, tolerability, and efficacy of cladribine tablets: a single center experience;Bain;Mult. Scler.,2020
5. Real world experience with cladribine at S. Andrea hospital of Rome;Barbuti;J. Neurol. Sci.,2021
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献